A prescription for the US FDA for the regulation of health misinformation

被引:3
|
作者
Kadakia, Kushal T. [1 ]
Beckman, Adam L. [1 ,2 ]
Krumholz, Harlan M. [3 ,4 ,5 ]
机构
[1] Harvard Med Sch, Boston, MA USA
[2] Harvard Sch Business, Boston, MA USA
[3] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA
[4] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA
[5] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
D O I
10.1038/s41591-022-02172-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The US Food and Drug Administration should address health misinformation through existing and new regulatory approaches, including modernizing product labeling, investing in infodemic surveillance and addressing the roles of the internet and social media.
引用
收藏
页码:525 / 527
页数:3
相关论文
共 50 条
  • [42] US FDA halts use of triclosan in health care antiseptics
    Hogue, Cheryl
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (01) : 15 - 15
  • [43] The menacing assaults on science, FDA, CDC, and health of the US public
    Alter, Scott M.
    Maki, Dennis G.
    LeBlang, Suzanne
    Shih, Richard D.
    Hennekens, Charles H.
    ECLINICALMEDICINE, 2020, 27
  • [44] US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007
    Gruber, Marion F.
    EXPERT REVIEW OF VACCINES, 2011, 10 (07) : 1011 - 1019
  • [45] FDA PUSHES FOR PRESCRIPTION DRUG INFORMATION
    MARWICK, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (23): : 1815 - 1816
  • [46] Mitigating Health Risks of Prescription Drugs Lessons From FDA Oversight of Opioid Products
    Sarpatwari, Ameet
    Curfman, Gregory
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (07): : 651 - 653
  • [47] Supporting real advances in public health through FDA regulation
    Givel, MS
    JOURNAL OF PUBLIC HEALTH POLICY, 2006, 27 (01) : 119 - 120
  • [48] HEALTH REGULATION OF NATURALLY HAZARDOUS FOODS - FDA BAN ON SWORDFISH
    不详
    HARVARD LAW REVIEW, 1972, 85 (05) : 1025 - 1075
  • [49] FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
    Warraich, Haider J.
    Tazbaz, Troy
    Califf, Robert M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (03): : 241 - 247
  • [50] FDA Regulation of Tobacco Politics, Law, and the Public's Health
    Gostin, Lawrence O.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (13): : 1459 - 1460